![Avery Catlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Avery Catlin
Directeur/Bestuurslid bij
Corbus Pharmaceuticals, Inc.
Profiel
Avery W.
Catlin is currently the Director at Corbus Pharmaceuticals, Inc. and the Vice President at CuraGen Corp.
Previously, he served as the Independent Director at Provention Bio, Inc. from 2018 to 2023 and at Corbus Pharmaceuticals Holdings, Inc. from 2014 to 2024.
He also held the position of Chief Financial Officer at MediSense, Inc. and Repligen Corp.
from 1992 to 1996 and Chief Financial Officer & VP-Operations at Endogen, Inc. from 1996 to 1999.
From 2000 to 2008, he was the Chief Financial Officer, Secretary & SVP at AVANT Immunotherapeutics, Inc. and from 2011 to 2017, he served as the CFO, Secretary, Treasurer & Senior Vice President at Celldex Therapeutics, Inc. Mr. Catlin completed his undergraduate degree at the University of Virginia and holds an MBA from Babson College.
Actieve functies van Avery Catlin
| Bedrijven | Functie | Begin |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | - |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Bestuurslid | - |
Eerdere bekende functies van Avery Catlin
| Bedrijven | Functie | Einde |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Bestuurslid | 15-08-2024 |
| PROVENTION BIO, INC. | Directeur/Bestuurslid | 27-04-2023 |
| CELLDEX THERAPEUTICS, INC. | Financieel Directeur/CFO | 30-06-2017 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Financieel Directeur/CFO | 01-10-2008 |
Endogen, Inc.
 Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Financieel Directeur/CFO | 01-01-1999 |
Opleiding van Avery Catlin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
50
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
MediSense, Inc.
 MediSense, Inc. Medical SpecialtiesHealth Technology Provides blood-glucose monitoring systems | Health Technology |
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Endogen, Inc.
Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
